In a Central Asian study of an early-onset Parkinson’s disease population in Kazakhstan, pathogenic mutations were found in only 6% of cases and only in the LRRK2 and PRKN genes, confirming regional differences between populations [46]. This evidence concerns the gene LRRK2 and Parkinson disease.